With funding from the University’s COVID Action Fund Initiative, SGC and BioZone have established the Toronto Open Access COVID-19 Protein Manufacturing Center
Please order your proteins here: https://www.biozone.utoronto.ca/covid-19-protein-manufacturing-center/
Our protein purification team at BioZone or SGC will produce any SARS-CoV-2 protein without restriction for any Canadian business or academic.
The virus causing COVID-19, SARS-CoV-2, encodes 25 proteins in its genome. Collectively, these proteins are responsible for all viral pathogenic functions, including cellular attachment and infiltration, translation of the viral RNA genome into the viral proteins, immune system evasion, assembly of new virions, and escape from the host cell. Most if not all of these proteins are under intense investigation by organizations world-wide into their basic biochemistry/biology, as targets for novel antiviral compounds, as targets for viral neutralizing antibodies, as reagents for diagnostics, and for vaccine development. A foundational component for all of these initiatives is access to high-quality purified viral protein.